Family Medicine · Glendale, CA
NPI
1952505125
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1332 S. Glendale Ave
Glendale, CA, 91205
Phone (818) 243-4344
Groups this clinician bills Medicare through
Medicare paid, 2024
$673K
13,818 services
Medicare patients, 2024
567
Average age 75
Drug cost, 2024
$5.0M
37,476 prescriptions
Company payments, 2025
$364
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hrachya Paruyryan was code 99457 (e&m - miscellaneous), 2,266 times for 310 patients. In total Hrachya Paruyryan billed 13,818 services in 45 codes, and Medicare paid $673K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99457 E&M - Miscellaneous | Office | 2,266 | 310 | $40.48 | $92K |
| 99454 E&M - Miscellaneous | Office | 2,012 | 284 | $41.34 | $83K |
| 99214 Office E&M - Established | Office | 1,857 | 521 | $107.23 | $199K |
| 36415 Venipuncture Blood Collection | Office | 1,345 | 484 | $8.65 | $12K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 789 | 252 | $26.99 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 759 | 350 | $13.19 | $10K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 501 | 501 | $27.02 | $14K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 497 | 497 | $21.26 | $11K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 465 | 465 | $21.26 | $9,885 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 443 | 443 | $141.41 | $63K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 423 | 283 | $51.39 | $22K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 313 | 169 | $34.38 | $11K |
| G0008 Administration of influenza virus vaccine | Office | 264 | 264 | $35.02 | $9,245 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 260 | 171 | $42.72 | $11K |
| 99213 Office E&M - Established | Office | 256 | 173 | $74.39 | $19K |
By year: 2022 $833K for 15,467 services; 2023 $779K for 14,670 services; 2024 $673K for 13,818 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,345 | 484 | $8.65 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Hrachya Paruyryan prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,722 prescriptions and refills. In total Hrachya Paruyryan wrote 37,476 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,722 | 2,134 | 215 | $9,445 |
| Atorvastatin Calcium Generic | 1,687 | 2,280 | 237 | $7,143 |
| Amlodipine Besylate Generic | 1,516 | 1,907 | 200 | $2,743 |
| Vascepa Icosapent Ethyl | 973 | 1,005 | 120 | $340K |
| Hydralazine Hcl Generic | 843 | 1,006 | 104 | $4,755 |
| Levothyroxine Sodium Generic | 800 | 1,061 | 101 | $4,277 |
| Gabapentin Generic | 784 | 842 | 93 | $2,858 |
| Metoprolol Succinate Generic | 747 | 933 | 94 | $3,965 |
| Furosemide Generic | 718 | 795 | 82 | $1,153 |
| Metformin Hcl Generic | 715 | 988 | 107 | $1,943 |
| Trazodone Hcl Generic | 693 | 779 | 86 | $1,689 |
| Omeprazole Generic | 665 | 777 | 85 | $2,442 |
| Carvedilol Generic | 664 | 810 | 90 | $1,880 |
| Dexlansoprazole Dr Dexlansoprazole | 651 | 688 | 78 | $118K |
| Tamsulosin Hcl Generic | 606 | 732 | 79 | $2,610 |
Brand drugs: 8,048 claims; generic drugs: 28,714 claims; opioid claims: 251.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hrachya Paruyryan $364 ($364 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $61.79.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 3 | $61.79 |
| Abbvie Inc. ABBV | 2 | $52.13 |
| Axsome Therapeutics, Inc. AXSM | 2 | $46.85 |
| GlaxoSmithKline, LLC. GSK | 2 | $40.63 |
| Eisai Inc. 4523.T | 1 | $33.86 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $30 |
| TG Therapeutics, Inc. TGTX | 1 | $27.63 |
| Amgen Inc. AMGN | 1 | $25.87 |
| Novo Nordisk Inc NVO | 1 | $24.97 |
| Lilly USA, LLC LLY | 1 | $20.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.